These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9771742)

  • 1. Protein conformation dictates prion strain.
    Aguzzi A
    Nat Med; 1998 Oct; 4(10):1125-6. PubMed ID: 9771742
    [No Abstract]   [Full Text] [Related]  

  • 2. Eight prion strains have PrP(Sc) molecules with different conformations.
    Safar J; Wille H; Itri V; Groth D; Serban H; Torchia M; Cohen FE; Prusiner SB
    Nat Med; 1998 Oct; 4(10):1157-65. PubMed ID: 9771749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing for prions: recognizing misfolded PrP.
    Caughey B
    Nat Med; 2003 Jul; 9(7):819-20. PubMed ID: 12835691
    [No Abstract]   [Full Text] [Related]  

  • 4. Conformational exposure: a new handle on prions.
    Brown DR
    Lancet; 2003 Sep; 362(9388):929-30. PubMed ID: 14511922
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomedicine. A view from the top--prion diseases from 10,000 feet.
    Priola SA; Chesebro B; Caughey B
    Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843
    [No Abstract]   [Full Text] [Related]  

  • 6. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
    Thackray AM; Hopkins L; Bujdoso R
    Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prion protein epitope selective for the pathologically misfolded conformation.
    Paramithiotis E; Pinard M; Lawton T; LaBoissiere S; Leathers VL; Zou WQ; Estey LA; Lamontagne J; Lehto MT; Kondejewski LH; Francoeur GP; Papadopoulos M; Haghighat A; Spatz SJ; Head M; Will R; Ironside J; O'Rourke K; Tonelli Q; Ledebur HC; Chakrabartty A; Cashman NR
    Nat Med; 2003 Jul; 9(7):893-9. PubMed ID: 12778138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The state of the prion.
    Weissmann C
    Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody.
    Moroncini G; Mangieri M; Morbin M; Mazzoleni G; Ghetti B; Gabrielli A; Williamson RA; Giaccone G; Tagliavini F
    Neurobiol Dis; 2006 Sep; 23(3):717-24. PubMed ID: 16876426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell biology. Prion toxicity: all sail and no anchor.
    Aguzzi A
    Science; 2005 Jun; 308(5727):1420-1. PubMed ID: 15933188
    [No Abstract]   [Full Text] [Related]  

  • 11. More tools for prion research.
    Bradbury J
    Drug Discov Today; 2004 Oct; 9(19):821-2. PubMed ID: 15381128
    [No Abstract]   [Full Text] [Related]  

  • 12. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions.
    Wang F; Yang F; Hu Y; Wang X; Wang X; Jin C; Ma J
    Biochemistry; 2007 Jun; 46(23):7045-53. PubMed ID: 17503780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies.
    Kim CL; Umetani A; Matsui T; Ishiguro N; Shinagawa M; Horiuchi M
    Virology; 2004 Mar; 320(1):40-51. PubMed ID: 15003861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro self-propagation of recombinant PrPSc-like conformation generated in the yeast cytoplasm.
    Yang W; Yang H; Tien P
    FEBS Lett; 2006 Jul; 580(17):4231-5. PubMed ID: 16831424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing therapeutics for the diseases of protein misfolding.
    May BC; Govaerts C; Cohen FE
    Neurology; 2006 Jan; 66(2 Suppl 1):S118-22. PubMed ID: 16432139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal cleavage site of PrPSc from BSE differs from that of PrPSc from scrapie.
    Hayashi HK; Yokoyama T; Takata M; Iwamaru Y; Imamura M; Ushiki YK; Shinagawa M
    Biochem Biophys Res Commun; 2005 Mar; 328(4):1024-7. PubMed ID: 15707980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnostic tools in Creutzfeldt-Jakob disease and other prion disorders.
    Van Everbroeck B; Boons J; De Leenheir E; Lübke U; Cras P
    Expert Rev Mol Diagn; 2004 May; 4(3):351-9. PubMed ID: 15137902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.
    Lau AL; Yam AY; Michelitsch MM; Wang X; Gao C; Goodson RJ; Shimizu R; Timoteo G; Hall J; Medina-Selby A; Coit D; McCoin C; Phelps B; Wu P; Hu C; Chien D; Peretz D
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11551-6. PubMed ID: 17601775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why are prion diseases precluded by non-mammals?
    Ji HF; Zhang HY; Chen LL
    Trends Biochem Sci; 2007 May; 32(5):206-8; discussion 208. PubMed ID: 17419063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.